270 related articles for article (PubMed ID: 12672241)
1. Novel, highly potent aldose reductase inhibitors: cyano(2-oxo-2,3-dihydroindol-3-yl)acetic acid derivatives.
Da Settimo F; Primofiore G; Da Settimo A; La Motta C; Simorini F; Novellino E; Greco G; Lavecchia A; Boldrini E
J Med Chem; 2003 Apr; 46(8):1419-28. PubMed ID: 12672241
[TBL] [Abstract][Full Text] [Related]
2. Naphtho[1,2-d]isothiazole acetic acid derivatives as a novel class of selective aldose reductase inhibitors.
Da Settimo F; Primofiore G; La Motta C; Sartini S; Taliani S; Simorini F; Marini AM; Lavecchia A; Novellino E; Boldrini E
J Med Chem; 2005 Nov; 48(22):6897-907. PubMed ID: 16250648
[TBL] [Abstract][Full Text] [Related]
3. Acetic acid aldose reductase inhibitors bearing a five-membered heterocyclic core with potent topical activity in a visual impairment rat model.
La Motta C; Sartini S; Salerno S; Simorini F; Taliani S; Marini AM; Da Settimo F; Marinelli L; Limongelli V; Novellino E
J Med Chem; 2008 Jun; 51(11):3182-93. PubMed ID: 18452283
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of [1,2,4]triazino[4,3-a] benzimidazole acetic acid derivatives as selective aldose reductase inhibitors.
Sahoo PK; Behera P
Eur J Med Chem; 2010 Mar; 45(3):909-14. PubMed ID: 19962793
[TBL] [Abstract][Full Text] [Related]
5. Spirohydantoin derivatives of thiopyrano[2,3-b]pyridin-4(4H)-one as potent in vitro and in vivo aldose reductase inhibitors.
Da Settimo F; Primofiore G; La Motta C; Salerno S; Novellino E; Greco G; Lavecchia A; Laneri S; Boldrini E
Bioorg Med Chem; 2005 Jan; 13(2):491-9. PubMed ID: 15598571
[TBL] [Abstract][Full Text] [Related]
6. [1,2,4]Triazino[4,3-a]benzimidazole acetic acid derivatives: a new class of selective aldose reductase inhibitors.
Da Settimo F; Primofiore G; Da Settimo A; La Motta C; Taliani S; Simorini F; Novellino E; Greco G; Lavecchia A; Boldrini E
J Med Chem; 2001 Dec; 44(25):4359-69. PubMed ID: 11728182
[TBL] [Abstract][Full Text] [Related]
7. Rational design of an indolebutanoic acid derivative as a novel aldose reductase inhibitor based on docking and 3D QSAR studies of phenethylamine derivatives.
Sun WS; Park YS; Yoo J; Park KD; Kim SH; Kim JH; Park HJ
J Med Chem; 2003 Dec; 46(26):5619-27. PubMed ID: 14667216
[TBL] [Abstract][Full Text] [Related]
8. Carboxymethylated pyridoindole antioxidants as aldose reductase inhibitors: Synthesis, activity, partitioning, and molecular modeling.
Stefek M; Snirc V; Djoubissie PO; Majekova M; Demopoulos V; Rackova L; Bezakova Z; Karasu C; Carbone V; El-Kabbani O
Bioorg Med Chem; 2008 May; 16(9):4908-20. PubMed ID: 18395454
[TBL] [Abstract][Full Text] [Related]
9. Substituted pyrrol-1-ylacetic acids that combine aldose reductase enzyme inhibitory activity and ability to prevent the nonenzymatic irreversible modification of proteins from monosaccharides.
Nicolaou I; Demopoulos VJ
J Med Chem; 2003 Jan; 46(3):417-26. PubMed ID: 12540241
[TBL] [Abstract][Full Text] [Related]
10. Discovery of [3-(4,5,7-trifluoro-benzothiazol-2-ylmethyl)-pyrrolo[2,3-b]pyridin-1-yl]acetic acids as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications.
Van Zandt MC; Doan B; Sawicki DR; Sredy J; Podjarny AD
Bioorg Med Chem Lett; 2009 Apr; 19(7):2006-8. PubMed ID: 19250825
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of potent and selective aldose reductase inhibitors based on pyridylthiadiazine scaffold.
Chen X; Yang Y; Ma B; Zhang S; He M; Gui D; Hussain S; Jing C; Zhu C; Yu Q; Liu Y
Eur J Med Chem; 2011 May; 46(5):1536-44. PubMed ID: 21367494
[TBL] [Abstract][Full Text] [Related]
12. Acid derivatives of benzisothiazole-1,1-dioxide as inhibitors of rat lens aldose reductase.
Da Settimo A; Primofiore G; La Motta C; Da Settimo F; Simorini F; Boldrini E; Bianchini P
Farmaco; 1996 Apr; 51(4):261-7. PubMed ID: 8645413
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of novel (1-thioxo-1,2,3,4-tetrahydro-β-carbolin-9-yl)acetic acids as selective inhibitors for AKR1B1.
Minehira D; Takeda D; Urata H; Kato A; Adachi I; Wang X; Matsuya Y; Sugimoto K; Takemura M; Endo S; Matsunaga T; Hara A; Koseki J; Narukawa K; Hirono S; Toyooka N
Bioorg Med Chem; 2012 Jan; 20(1):356-67. PubMed ID: 22104435
[TBL] [Abstract][Full Text] [Related]
14. Highly selective aldose reductase inhibitors. 3. Structural diversity of 3-(arylmethyl)-2,4,5-trioxoimidazolidine-1-acetic acids.
Kotani T; Nagaki Y; Ishii A; Konishi Y; Yago H; Suehiro S; Okukado N; Okamoto K
J Med Chem; 1997 Feb; 40(5):684-94. PubMed ID: 9057855
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of novel aldose reductase inhibitors: Effects on lens protein kinase Cgamma.
Lewis S; Karrer J; Saleh S; Chan X; Tan Z; Hua D; McGill J; Pang YP; Fenwick B; Brightman A; Takemoto D
Mol Vis; 2001 Jul; 7():164-71. PubMed ID: 11483892
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships and molecular modelling of 5-arylidene-2,4-thiazolidinediones active as aldose reductase inhibitors.
Maccari R; Ottanà R; Curinga C; Vigorita MG; Rakowitz D; Steindl T; Langer T
Bioorg Med Chem; 2005 Apr; 13(8):2809-23. PubMed ID: 15781392
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, activity, and molecular modeling of new 2, 4-dioxo-5-(naphthylmethylene)-3-thiazolidineacetic acids and 2-thioxo analogues as potent aldose reductase inhibitors.
Fresneau P; Cussac M; Morand JM; Szymonski B; Tranqui D; Leclerc G
J Med Chem; 1998 Nov; 41(24):4706-15. PubMed ID: 9822541
[TBL] [Abstract][Full Text] [Related]
18. (2-Benzyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-8-yl)-acetic acid: an aldose reductase inhibitor and antioxidant of zwitterionic nature.
Stefek M; Tsantili-Kakoulidou A; Milackova I; Juskova M; Snirc V; Triantos N
Bioorg Med Chem; 2011 Dec; 19(23):7181-5. PubMed ID: 22037047
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of 2'-oxo-2,3-dihydro-3'H- spiro[chromene-4,5'-[1,3]oxazolidin]-3'yl]acetic acid derivatives as aldose reductase inhibitors.
Rapposelli S; Da Settimo F; Digiacomo M; La Motta C; Lapucci A; Sartini S; Vanni M
Arch Pharm (Weinheim); 2011 Jun; 344(6):372-85. PubMed ID: 21319207
[TBL] [Abstract][Full Text] [Related]
20. 1,2-Benzothiazine 1,1-dioxide carboxylate derivatives as novel potent inhibitors of aldose reductase.
Chen X; Zhang S; Yang Y; Hussain S; He M; Gui D; Ma B; Jing C; Qiao Z; Zhu C; Yu Q
Bioorg Med Chem; 2011 Dec; 19(23):7262-9. PubMed ID: 22036211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
